Log in
Sign up
Pfizer

Pfizer

Pfizer is an American, multinational pharmaceutical and biotechnology corporation.

OverviewStructured DataIssuesContributorsActivity
Contents

Pfizer is an American, multinational pharmaceutical and biotechnology corporation. The company was founded in 1849 by two German immigrants, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891), in New York, New York, United States.

Pfizer has the mission to fund programs that provide public benefit, advance medical care, and can improve patient outcomes. Their researchers preform 25,000 clinical tests everyday for pharmaceutical development and innovations.

Nowadays Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.

Partnerships
BaseLaunch

Pfizer is a partner with the BaseLaunch startup accelerator. The BaseLaunch program receives applications in the fields of therapeutics, diagnostics, digital healthcare, healthcare services, therapeutic platforms, and medical technology.

Insilico Medicine

Insilico Medicine and Pfizer entered into a research collaboration agreement. The agreement allows Pfizer to utilize Insilico Medicine's machine learning technology and Pandomics Discovery Platform to research potential therapeutic targets for a variety of diseases.

AMRA Medical

AMRA Medical and Pfizer's partnership works to investigate body fat distribution and muscle composition in a range of diseases using the UK Biobank registry. The partnership involves the body composition analysis of 100,000 individuals.

CytoReason

Pfizer's partnership with CytoReason gives them access to CytoReason's machine learning platform for drug discovery and development.

XtalPi Inc.

XtalPi Inc. and Pfizer's research collaboration focuses on developing a hybrid physics-and artificial intelligence-powered software platform for accurate molecular modeling of small molecules. The platform is intended to advance both companies capabilities in drug design and solid-form selection.

Distributed Bio

Pfizer and Distributed Bio entered an agreement to license Distributed Bio's SuperHuman Platform to Pfizer. The SuperHuman 2.0 antibody discovery platform will allow Pfizer to utilize the antibody library for screening activities against Pfizer-selected targets.

Domain Therapeutics

Domain Therapeutics and Pfizer entered into a collaboration agreement to asses Domain Therapeutics's bioSensAll platform. The bioSensAll platform defines signaling signatures for each wild-type and mutant receptors. Pfizer aims to use the platform to assess the impact of mutations on different signaling pathways engaged by g protein-coupled receptors.

COVID-19

Pfizer announced that they have identified certain anti-viral compounds that are under development which could be effective in treating the novel coronavirus SARS-CoV-2 responsible for COVID-19. They may enter a partnership with a third party company to screen and identify potential compounds by the end of March, 2020 in order to begin testing in April, 2020.

Pfizer is partnered with BioNTech for co-development and distribution of an mRNA vaccine against SARS-CoV-2 called BNT162.

Timeline

No Timeline data yet.

Invested in

Open in Query Tool

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

Breaking the Rules of Biology to Beat Rare Genetic Disease | Pfizer

https://www.pfizer.com/news/featured_stories/featured_stories_detail/breaking_the_rules_of_biology_to_beat_rare_genetic_disease

Web

Our Science: Pharmaceutical Development | Pfizer | Pfizer

https://www.pfizer.com/science

Web

Pfizer | Crunchbase

https://www.crunchbase.com/organization/pfizer#section-overview

Web

Pfizer's Core Values of Social Responsibility and Philanthropy | Pfizer

https://www.pfizer.com/purpose

Web

What to Know About Coronavirus -- COVID-19 Explained | Pfizer

https://www.pfizer.com/news/hot-topics/what_to_know_about_coronavirus_covid_19_explained

Web

References

pfizer.com
pfizer.co.jp...ex.html
pfizer.co.jp
Is a
Organization
Organization
Company
Company
Investor
Investor

Company attributes

Industry
Internal medicine
Internal medicine
Infectious disease (medical specialty)
Infectious disease (medical specialty)
Biotechnology
Biotechnology
Biology
Biology
Clinical trial
Clinical trial
Technology
Technology
Cell therapy
Cell therapy
...
Location
Anderlecht
Anderlecht
Puurs
Puurs
Dalian
Dalian
Buenos Aires
Buenos Aires
Suzhou
Suzhou
North Carolina
North Carolina
San Diego
San Diego
Japan
Japan
...
B2X
B2C
B2C
CEO
Albert Bourla
Albert Bourla
-1
Founder
‌
Charles F. Erhart
Charles Pfizer
Charles Pfizer
AngelList URL
angel.co/pfizer
Pitchbook URL
pitchbook.com/profiles.../11597-86
Legal Name
Pfizer Inc.
Parent Organization
State Street Corporation
State Street Corporation
Pfizer
Pfizer
BlackRock
BlackRock
Subsidiary
‌
Warner–Lambert
‌
Vicuron
‌
Hospira
Pfizer Venture Investments
Pfizer Venture Investments
Zoetis
Zoetis
-1
Wyeth
Wyeth
G.D. Searle, LLC
G.D. Searle, LLC
ViiV Healthcare
ViiV Healthcare
...
Legal classification
Private limited company
Private limited company
Public company
Public company
Date Incorporated
November 27, 1953
Number of Employees (Ranges)
10,001+
Number of Employees
88,300
Full Address
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ
235 East 42nd Street NY, NY 10017-1
CIK Number
78,003
Incorporation Reference
00526209
DUNS Number
001326495
Founded Date
1849
Email Address
pfizercentreone@pfizer.com
Phone Number
+18008793477-1
+18884058668
+12125732323-1
Competitors
Minskintercaps
Minskintercaps
Borisov plant of medical preparations
Borisov plant of medical preparations
Moderna Therapeutics
Moderna Therapeutics
AstraZeneca
AstraZeneca
Roche
Roche
Meissa Vaccines
Meissa Vaccines
Sputnik V
Sputnik V
Business Model
Commerce
Stock Symbol
PFE
Exchange
New York Stock Exchange
New York Stock Exchange
Glassdoor ID
525
Board of Directors
James Quincey
James Quincey
-1
Scott Gottlieb
Scott Gottlieb
-1
Susan Desmond-Hellmann
Susan Desmond-Hellmann
-1
‌
Suzanne Nora Johnson
-1
Shantanu Narayen
Shantanu Narayen
-1
Susan Hockfield
Susan Hockfield
-1
Dan R. Littman
Dan R. Littman
-1
Joseph J. Echevarria
Joseph J. Echevarria
-1
...
CTO
Lidia Fonseca
Lidia Fonseca
-1
CFO
‌
Dave Denton
-1
Former CEO
Ian Read
Ian Read
Key People
Frank D'Amelio
Frank D'Amelio
Sally Susman
Sally Susman
-1
Mikael Dolsten
Mikael Dolsten
Doug Lankler
Doug Lankler
-1
Albert Bourla
Albert Bourla
-1
Bill Carapezzi
Bill Carapezzi
-1
Lidia Fonseca
Lidia Fonseca
-1
Angela Hwang
Angela Hwang
-1
...
Also Known As
Pfizer–BioNTech
Pfizer Limited
NAICS Code
325,411
CAGE Code
86491
Patents Assigned (Count)
202
Legal Entity Identifier
765LHXWGK1KXCLTFYQ30-1
COO
Albert Bourla
Albert Bourla
Motto/Tagline
Health for All
Wellfound ID
pfizer
Technologies Used
CRISPR
CRISPR
Country
United Kingdom
United Kingdom
Republic of Ireland
Republic of Ireland
Japan
Japan
United States
United States
-1
Headquarters
New York
New York

Other attributes

Blog
pfizercentreone.com/blog
Company Operating Status
Active
Strategic Partnerships
Virtus Pharmaceuticals
Virtus Pharmaceuticals
-1
Contact Page URL
pfizer.com/contact
Market Capitalization
203,200,000,000
Named After
Charles Pfizer
Charles Pfizer
Official Name
Pfizer Inc.
Owner
King Pharmaceuticals
King Pharmaceuticals
Owner of
‌
Robitussin
Medivation
Medivation
Wyeth
Wyeth
Partner Organizations
‌
Wok digital
Short Name
PFE-1
Ticker Symbol
PFE
UKSIC Code
46460, 72190
Wikidata ID
Q206921

Find more companies like Pfizer

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
Knowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.